Neuralstem Cash from Operations Quarterly:
-2.518M for Dec. 31, 2012Neuralstem Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -2.518M |
| Sept. 30, 2012 | -1.420M |
| June 30, 2012 | -2.439M |
| March 31, 2012 | -2.101M |
| Dec. 31, 2011 | -1.783M |
| Sept. 30, 2011 | -1.814M |
| June 30, 2011 | -2.212M |
| March 31, 2011 | -2.288M |
| Dec. 31, 2010 | -2.750M |
| Sept. 30, 2010 | -2.353M |
| June 30, 2010 | -2.752M |
| March 31, 2010 | -2.127M |
| Dec. 31, 2009 | -1.532M |
| Sept. 30, 2009 | -1.085M |
| June 30, 2009 | -1.231M |
| March 31, 2009 | -1.297M |
| Dec. 31, 2008 | -2.129M |
| Sept. 30, 2008 | -1.653M |
| June 30, 2008 | -1.390M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
CUR Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Neostem | -9.625M |
| Pluristem Therapeutic | -3.368M |
| StemCells | -4.920M |
CUR Cash from Operations Quarterly Rankings
| Overall |
52nd percentile 3775 of 8002 |
| Sector |
45th percentile 370 of 684 in Healthcare |
| Industry |
63rd percentile 91 of 248 in Biotechnology |
CUR Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -2.752M | Jun 2010 |
| Maximum | -1.085M | Sep 2009 |
| Average | -1.941M |
